BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9760548)

  • 1. [The assessment of lamotrigine effectiveness in patients with drug-resistant epilepsy].
    Małowidzka-Serwińska M
    Neurol Neurochir Pol; 1998; 32(2):285-93. PubMed ID: 9760548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lamotrigine in add-on therapy: assessment of efficacy in drug resistant epilepsy].
    Juryńczyk J; Weglewski A
    Neurol Neurochir Pol; 2000; 34(1):43-7. PubMed ID: 10849903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lamotrigine: monotherapy in refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Apr; 148(4):153-8. PubMed ID: 9377849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
    Ramey P; Osborn M; Abou-Khalil B
    Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
    Kaminow L; Schimschock JR; Hammer AE; Vuong A
    Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of Gabitril and Lamictal for drug-resistant epilepsy in adults.
    Chmielewska B; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():35-42. PubMed ID: 11977339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy.
    Gamble C; Williamson PR; Chadwick DW; Marson AG
    Neurology; 2006 May; 66(9):1310-7. PubMed ID: 16682660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
    Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
    Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of add-on treatment with lamotrigine in partial epilepsy.
    Smith D; Baker G; Davies G; Dewey M; Chadwick DW
    Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK; Kustra RP; Hammer AE
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lamotrigine: first experience in Italy].
    de Romanis F; Sopranzi N
    Clin Ter; 1995 Mar; 146(3):203-9. PubMed ID: 7789082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of lamotrigine monotherapy in children with newly diagnosed partial epilepsy].
    Sołowiej E; Sobaniec W; Kozik A; Ujma-Czapska B
    Neurol Neurochir Pol; 2000; 34 Suppl 1():129-41. PubMed ID: 10768153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.
    Reunanen M; Dam M; Yuen AW
    Epilepsy Res; 1996 Mar; 23(2):149-55. PubMed ID: 8964276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination vigabatrin and lamotrigine therapy for intractable epilepsy.
    Schapel GJ; Black AB; Lam EL; Robinson M; Dollman WB
    Seizure; 1996 Mar; 5(1):51-6. PubMed ID: 8777553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.